The Business of Biofabrication

Biofabrication rarely advances through hardware, biomaterials, or cells alone. The more interesting opportunities often emerge when those capabilities come together around a specific biological question. That is something Linton Lifesciences and ClonalStem have recently been exploring through work involving cord-blood-derived endothelial colony-forming cells (CB-ECFCs) and engineered biomaterials for vascular applications. The work looks at how…